Pages that link to "Q46723268"
Jump to navigation
Jump to search
The following pages link to Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure (Q46723268):
Displaying 47 items.
- Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis (Q26746998) (← links)
- Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus (Q27014826) (← links)
- EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. (Q30375302) (← links)
- Analysis on differential gene expression data for prediction of new biological features in permanent atrial fibrillation (Q30690800) (← links)
- Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation (Q33664832) (← links)
- Pharmacological management of atrial fibrillation: one, none, one hundred thousand. (Q33902193) (← links)
- Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes (Q34388593) (← links)
- Effects of candesartan, an angiotensin II receptor type I blocker, on atrial remodeling in spontaneously hypertensive rats (Q35294169) (← links)
- Novel pharmacological targets for the rhythm control management of atrial fibrillation. (Q35489060) (← links)
- Inflammatory cytokines and atrial fibrillation: current and prospective views (Q35557385) (← links)
- Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study (Q36032507) (← links)
- Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis (Q36337187) (← links)
- Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation (Q36943418) (← links)
- Effect of High-dose Telmisartan on the Prevention of Recurrent Atrial Fibrillation in Hypertensive Patients (Q37114614) (← links)
- Antioxidant therapies for the management of atrial fibrillation (Q37339307) (← links)
- Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker. (Q37457719) (← links)
- Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation (Q37496071) (← links)
- Upstream therapy of atrial fibrillation (Q37546133) (← links)
- New pharmacological strategies for the treatment of atrial fibrillation (Q37554693) (← links)
- Atrial fibrillation: mechanisms, therapeutics, and future directions (Q37590158) (← links)
- New antiarrhythmic drugs for treatment of atrial fibrillation. (Q37718340) (← links)
- Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. (Q37809401) (← links)
- Mechanisms of termination and prevention of atrial fibrillation by drug therapy (Q37844891) (← links)
- Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. (Q37846370) (← links)
- Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure. (Q37959068) (← links)
- Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies (Q38234313) (← links)
- Novel therapeutic targets in the management of atrial fibrillation (Q38236746) (← links)
- A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation (Q41955585) (← links)
- Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes (Q42368137) (← links)
- Inflammatory responses in the atria: Should they stay or should they go? (Q42694091) (← links)
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (Q45939560) (← links)
- Heart failure enhances arrhythmogenesis in pulmonary veins (Q46861633) (← links)
- A mechanical characterization of the porcine atria at the healthy stage and after ventricular tachypacing. (Q47934763) (← links)
- Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. (Q48194292) (← links)
- Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models. (Q54404882) (← links)
- PPAR-γ activation limits angiotensin II-mediated atrial remodeling: one drug fits all AF patients? (Q54468788) (← links)
- Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model (Q54611607) (← links)
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. (Q55638585) (← links)
- Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus (Q84062748) (← links)
- Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes (Q84963675) (← links)
- Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway (Q87649060) (← links)
- Rabbit models of heart disease (Q91910941) (← links)
- Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment (Q92065614) (← links)
- Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation (Q92462677) (← links)
- Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences (Q93074138) (← links)
- The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation (Q99239879) (← links)
- Relationship between red blood cell distribution width levels and atrial fibrillation in hypertensive patients (Q99578856) (← links)